Pages that link to "Double-blind"
Jump to navigation
Jump to search
The following pages link to Double-blind:
Displayed 38 items.
- Study design (← links)
- Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study (← links)
- Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial (← links)
- MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery (← links)
- Subject-expectancy effect (← links)
- Observer effect (← links)
- Objectivity (science) (← links)
- Idraparinux (← links)
- Anecdotal evidence (← links)
- Water memory (← links)
- Adderall detailed information (← links)
- Psilocybin detailed information (← links)
- Élan (← links)
- Placebo-controlled studies (← links)
- Results of the ATLAS ACS-TIMI 46 Study Published in The Lancet (← links)
- Endoscopic versus Open Harvesting of Saphenous Vein Grafts: Secondary PREVENT IV analysis published in New England Journal of Medicine (← links)
- Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study (← links)
- Determinants of Sapheous Vein Graft Patency (← links)
- Pericarditis treatment (← links)
- Retigabine (← links)
- Erectile dysfunction future or investigational therapies (← links)
- Lacosamide (← links)
- Cangrelor (← links)
- Lorcaserin Hydrochloride Hemihydrate (← links)
- Ruxolitinib (← links)
- Cyclacillin (← links)
- Briakinumab (← links)
- Ridaforolimus (← links)
- Acetaminophen (injection) (← links)
- Acetaminophen (infusion) (← links)
- Pyridoxine deficiency causes (← links)
- Cobimetinib (← links)
- Pimavanserin (← links)
- Sonidegib (← links)
- Ixazomib (← links)
- Lumacaftor and ivacaftor (← links)
- COVID-19 future or investigational therapies (← links)
- COVID-19-associated cytokine storm (← links)